Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2021 |
| Outros Autores: | , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | por |
| Título da fonte: | Research, Society and Development |
| Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/16758 |
Resumo: | The pandemic caused by COVID-19 brought a great concern to the population and its governments, as its spread is accelerated. In this context, a safe and effective treatment becomes urgent to treat and reduce probable complications, which can reduce the mortality caused by the disease. Drugs such as chloroquine and hydroxychloroquine began to be tested, these drugs were previously used around the world in the treatment of malaria and rheumatologic diseases. The study aims to analyze the consumption of medicines that underwent changes in their health regulations during the COVID-19 pandemic. An exploratory, retrospective descriptive study was carried out, and the methodological procedure was documentary in the evaluation of sales records of a drugstore in Teresina – PI. Therefore, it was found that during the study period, total sales equal to 5,526 of the drugs ivermectin, nitazoxanide and hydroxychloroquine were made. The results show a variation in drug sales, influenced by the increase and reduction of fatal cases at COVID-19. The use of these medications without a prescription from a qualified professional can cause serious damage to health and may even lead to death. |
| id |
UNIFEI_32fba4324abe7bcc7b27c75f36f87d30 |
|---|---|
| oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/16758 |
| network_acronym_str |
UNIFEI |
| network_name_str |
Research, Society and Development |
| repository_id_str |
|
| spelling |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic Análisis del consumo de drogas que sufrió cambios en su regulación sanitaria durante la pandemia del COVID-19Análise do consumo de medicamentos que sofreram alterações em sua regulamentação sanitária durante a pandemia do COVID-19 Infecções por coronavirusIvermectinaHidroxicloroquinaNitazoxanidaPandemias.Infecciones por coronavirusIvermectinaHidroxicloroquinaNitazoxanidaPandemias.Coronavirus infectionsIvermectinHydroxychloroquineNitazoxanidePandemics.The pandemic caused by COVID-19 brought a great concern to the population and its governments, as its spread is accelerated. In this context, a safe and effective treatment becomes urgent to treat and reduce probable complications, which can reduce the mortality caused by the disease. Drugs such as chloroquine and hydroxychloroquine began to be tested, these drugs were previously used around the world in the treatment of malaria and rheumatologic diseases. The study aims to analyze the consumption of medicines that underwent changes in their health regulations during the COVID-19 pandemic. An exploratory, retrospective descriptive study was carried out, and the methodological procedure was documentary in the evaluation of sales records of a drugstore in Teresina – PI. Therefore, it was found that during the study period, total sales equal to 5,526 of the drugs ivermectin, nitazoxanide and hydroxychloroquine were made. The results show a variation in drug sales, influenced by the increase and reduction of fatal cases at COVID-19. The use of these medications without a prescription from a qualified professional can cause serious damage to health and may even lead to death.La pandemia provocada por COVID-19 trajo una gran preocupación a la población y sus gobiernos, ya que se acelera su propagación. En este contexto, se hace urgente un tratamiento seguro y eficaz para tratar y reducir las posibles complicaciones, que pueden reducir la mortalidad provocada por la enfermedad. Se comenzaron a probar medicamentos como la cloroquina y la hidroxicloroquina, estos medicamentos se usaban anteriormente en todo el mundo en el tratamiento de la malaria y enfermedades reumatológicas. El estudio tiene como objetivo analizar el consumo de medicamentos que sufrieron cambios en su normativa sanitaria durante la pandemia COVID-19. Se realizó un estudio exploratorio, descriptivo retrospectivo, y el procedimiento metodológico fue documental en la evaluación de los registros de ventas de una farmacia en Teresina - PI. Por lo tanto, se encontró que durante el período de estudio se realizaron ventas totales equivalentes a 5.526 de los medicamentos ivermectina, nitazoxanida e hidroxicloroquina. Los resultados muestran una variación en las ventas de medicamentos, influenciada por el aumento y reducción de casos fatales en COVID-19. El uso de estos medicamentos sin la prescripción de un profesional calificado puede causar graves daños a la salud e incluso provocar la muerte.A pandemia provocada pela COVID-19 trouxe uma grande preocupação para a população e seus governantes, pois sua propagação é acelerada. Neste contexto, um tratamento seguro e eficaz se torna urgente para tratar e reduzir prováveis complicações, podendo diminuir a mortalidade causada pela doença. Fármacos como a cloroquina e hidroxicloroquina começaram a ser testados, essas drogas já foram utilizadas anteriormente em todo o mundo no tratamento da malária e de doenças reumatológicas. O estudo apresenta como objetivo analisar o consumo dos medicamentos que sofreram alterações em sua regulamentação sanitária durante a pandemia do COVID-19. Foi realizado um estudo exploratório, descritivo retrospectivo, sendo o procedimento metodológico documental na avaliação dos registros de venda de uma drogaria de Teresina – PI. Diante disso, constatou-se que durante o período estudado foram realizadas vendas totais iguais a 5.526, dos fármacos ivermectina, nitazoxanida e hidroxicloroquina. Os resultados apresentam uma variação das vendas dos medicamentos, influenciável pelo aumento e redução de casos fatais da COVID-19. O uso destes medicamentos sem prescrição de um profissional qualificado pode acarretar sérios danos à saúde podendo levar até a morte.Research, Society and Development2021-06-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1675810.33448/rsd-v10i7.16758Research, Society and Development; Vol. 10 No. 7; e42710716758Research, Society and Development; Vol. 10 Núm. 7; e42710716758Research, Society and Development; v. 10 n. 7; e427107167582525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/16758/15018Copyright (c) 2021 Francisco das Chagas Araújo Sousa; Izamara Salviano dos Santos; Suellen Martins Barbosa; Alysson Kenned de Freitas Mesquita; Wenderson Costa da Silva; Francisco Laurdindo da Silva; Liana Cynthia de Macedo Reis; Marcos André Arrais de Sousa; Joelson da Silva Medeiros; Erika Galvão Figueredohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSousa, Francisco das Chagas Araújo Santos, Izamara Salviano dosBarbosa, Suellen MartinsMesquita, Alysson Kenned de FreitasSilva, Wenderson Costa da Silva, Francisco Laurdindo da Reis, Liana Cynthia de MacedoSousa, Marcos André Arrais deMedeiros, Joelson da SilvaFigueredo, Erika Galvão2021-07-18T21:07:03Zoai:ojs.pkp.sfu.ca:article/16758Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:37:13.606058Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
| dc.title.none.fl_str_mv |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic Análisis del consumo de drogas que sufrió cambios en su regulación sanitaria durante la pandemia del COVID-19 Análise do consumo de medicamentos que sofreram alterações em sua regulamentação sanitária durante a pandemia do COVID-19 |
| title |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic |
| spellingShingle |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic Sousa, Francisco das Chagas Araújo Infecções por coronavirus Ivermectina Hidroxicloroquina Nitazoxanida Pandemias. Infecciones por coronavirus Ivermectina Hidroxicloroquina Nitazoxanida Pandemias. Coronavirus infections Ivermectin Hydroxychloroquine Nitazoxanide Pandemics. |
| title_short |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic |
| title_full |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic |
| title_fullStr |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic |
| title_full_unstemmed |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic |
| title_sort |
Analysis of drug consumption that suffered changes in its health regulation during the COVID-19 pandemic |
| author |
Sousa, Francisco das Chagas Araújo |
| author_facet |
Sousa, Francisco das Chagas Araújo Santos, Izamara Salviano dos Barbosa, Suellen Martins Mesquita, Alysson Kenned de Freitas Silva, Wenderson Costa da Silva, Francisco Laurdindo da Reis, Liana Cynthia de Macedo Sousa, Marcos André Arrais de Medeiros, Joelson da Silva Figueredo, Erika Galvão |
| author_role |
author |
| author2 |
Santos, Izamara Salviano dos Barbosa, Suellen Martins Mesquita, Alysson Kenned de Freitas Silva, Wenderson Costa da Silva, Francisco Laurdindo da Reis, Liana Cynthia de Macedo Sousa, Marcos André Arrais de Medeiros, Joelson da Silva Figueredo, Erika Galvão |
| author2_role |
author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Sousa, Francisco das Chagas Araújo Santos, Izamara Salviano dos Barbosa, Suellen Martins Mesquita, Alysson Kenned de Freitas Silva, Wenderson Costa da Silva, Francisco Laurdindo da Reis, Liana Cynthia de Macedo Sousa, Marcos André Arrais de Medeiros, Joelson da Silva Figueredo, Erika Galvão |
| dc.subject.por.fl_str_mv |
Infecções por coronavirus Ivermectina Hidroxicloroquina Nitazoxanida Pandemias. Infecciones por coronavirus Ivermectina Hidroxicloroquina Nitazoxanida Pandemias. Coronavirus infections Ivermectin Hydroxychloroquine Nitazoxanide Pandemics. |
| topic |
Infecções por coronavirus Ivermectina Hidroxicloroquina Nitazoxanida Pandemias. Infecciones por coronavirus Ivermectina Hidroxicloroquina Nitazoxanida Pandemias. Coronavirus infections Ivermectin Hydroxychloroquine Nitazoxanide Pandemics. |
| description |
The pandemic caused by COVID-19 brought a great concern to the population and its governments, as its spread is accelerated. In this context, a safe and effective treatment becomes urgent to treat and reduce probable complications, which can reduce the mortality caused by the disease. Drugs such as chloroquine and hydroxychloroquine began to be tested, these drugs were previously used around the world in the treatment of malaria and rheumatologic diseases. The study aims to analyze the consumption of medicines that underwent changes in their health regulations during the COVID-19 pandemic. An exploratory, retrospective descriptive study was carried out, and the methodological procedure was documentary in the evaluation of sales records of a drugstore in Teresina – PI. Therefore, it was found that during the study period, total sales equal to 5,526 of the drugs ivermectin, nitazoxanide and hydroxychloroquine were made. The results show a variation in drug sales, influenced by the increase and reduction of fatal cases at COVID-19. The use of these medications without a prescription from a qualified professional can cause serious damage to health and may even lead to death. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021-06-29 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/16758 10.33448/rsd-v10i7.16758 |
| url |
https://rsdjournal.org/index.php/rsd/article/view/16758 |
| identifier_str_mv |
10.33448/rsd-v10i7.16758 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/16758/15018 |
| dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Research, Society and Development |
| publisher.none.fl_str_mv |
Research, Society and Development |
| dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 7; e42710716758 Research, Society and Development; Vol. 10 Núm. 7; e42710716758 Research, Society and Development; v. 10 n. 7; e42710716758 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
| instname_str |
Universidade Federal de Itajubá (UNIFEI) |
| instacron_str |
UNIFEI |
| institution |
UNIFEI |
| reponame_str |
Research, Society and Development |
| collection |
Research, Society and Development |
| repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
| repository.mail.fl_str_mv |
rsd.articles@gmail.com |
| _version_ |
1797052750873231360 |